AIG
VIGL

American International Group’s Vigil Neuroscience VIGL Stock Holding History

American International Group’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,919
Closed -$27K – 2634
2024
Q1 		$27K Sell
7,919
-68
-0.9% -$212 ﹤0.01% 2896
2023
Q4 		$27K Sell
7,987
-32
-0.4% -$165 ﹤0.01% 2931
2023
Q3 		$43.2K Buy
8,019
+285
+4% +$1.97K ﹤0.01% 2851
2023
Q2 		$72.7K Buy
+7,734
New +$73.1K ﹤0.01% 2761
2022
Q2 		– Sell
-3,332
Closed -$23K – 3271
2022
Q1 		$23K Buy
+3,332
New +$44K ﹤0.01% 3011

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

American International Group's VIGL Position: Q2 2024 in Review

American International Group sold out of Vigil Neuroscience (VIGL) in Q2 2024, closing a stake of 7,919 shares — an estimated $27K sold.

American International Group first reported a position in VIGL in Q1 2022 and held it in 5 quarters. The position peaked at $72.7K in Q2 2023. 58 funds tracked by Wall St. Rank hold VIGL as of Q2 2024.

  • American International Group reported no remaining Vigil Neuroscience position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 7,919 Vigil Neuroscience shares in Q2 2024, an estimated $27K.
  • American International Group first reported a position in Vigil Neuroscience in Q1 2022 and held it in 5 quarters.
  • American International Group's Vigil Neuroscience position peaked at $72.7K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.